STING1 and melanoma: The combination of cytotoxic cationic silica nanoparticles (CSiNPs) with STING agonists can activate tumor-infiltrating antigen-presenting cells resulting in increased expansion of antigen specific CD8+ T cells, and potent tumor growth inhibition in murine melanoma (93).